Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation

F. Biancari, M. Dalén, A. Fiore, VG. Ruggieri, D. Saeed, K. Jónsson, G. Gatti, S. Zipfel, A. Perrotti, K. Bounader, A. Loforte, A. Lechiancole, M. Pol, C. Spadaccio, M. Pettinari, S. Ragnarsson, K. Alkhamees, G. Mariscalco, H. Welp, PC-ECMO Study Group,

. 2020 ; 159 (5) : 1844-1854.e6. [pub] 20190702

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023056

OBJECTIVES: The aim of this study was to identify the risk factors associated with early mortality after postcardiotomy venoarterial extracorporeal membrane oxygenation. METHODS: This is an analysis of the postcardiotomy extracorporeal membrane oxygenation registry, a retrospective multicenter cohort study including 781 patients aged more than 18 years who required venoarterial extracorporeal membrane oxygenation for cardiopulmonary failure after cardiac surgery from 2010 to 2018 at 19 cardiac surgery centers. RESULTS: After a mean venoarterial extracorporeal membrane oxygenation therapy of 6.9 ± 6.2 days, hospital and 1-year mortality were 64.4% and 67.2%, respectively. Hospital mortality after venoarterial extracorporeal membrane oxygenation therapy for more than 7 days was 60.5% (P = .105). Centers that had treated more than 50 patients with postcardiotomy venoarterial extracorporeal membrane oxygenation had a significantly lower hospital mortality than lower-volume centers (60.7% vs 70.7%, adjusted odds ratio, 0.58; 95% confidence interval, 0.41-0.82). The postcardiotomy extracorporeal membrane oxygenation score was derived by assigning a weighted integer to each independent pre-venoarterial extracorporeal membrane oxygenation predictors of hospital mortality as follows: female gender (1 point), advanced age (60-69 years, 2 points; ≥70 years, 4 points), prior cardiac surgery (1 point), arterial lactate 6.0 mmol/L or greater before venoarterial extracorporeal membrane oxygenation (2 points), aortic arch surgery (4 points), and preoperative stroke/unconsciousness (5 points). The hospital mortality rates according to the postcardiotomy extracorporeal membrane oxygenation score was 0 point, 45.6%; 1 point, 40.5%; 2 points, 51.1%; 3 points, 57.8%; 4 points, 70.7%; 5 points, 68.3%; 6 points, 77.5%; and 7 points or more, 89.7% (P < .0001). CONCLUSIONS: Age, female gender, prior cardiac surgery, preoperative acute neurologic events, aortic arch surgery, and increased arterial lactate were associated with increased risk of early mortality after postcardiotomy venoarterial extracorporeal membrane oxygenation. Center experience with postcardiotomy venoarterial extracorporeal membrane oxygenation may contribute to improved results.

Cardiothoracic Department University Hospital of Udine Udine Italy

Cardiovascular Surgery University Hospital of Duesseldorf Dusseldorf Germany

Department of Cardiac Surgery Glenfield Hospital University Hospitals of Leicester Leicester United Kingdom

Department of Cardiac Surgery Sahlgrenska University Hospital Gothenburg Sweden

Department of Cardiothoracic Surgery Golden Jubilee National Hospital Glasgow United Kingdom

Department of Cardiothoracic Surgery Henri Mondor University Hospital AP HP Paris Est University Créteil France

Department of Cardiothoracic Surgery Münster University Hospital Münster Germany

Department of Cardiothoracic Surgery University of Lund Lund Sweden

Department of Cardiothoracic Transplantation and Vascular Surgery S Orsola Hospital University of Bologna Bologna Italy

Department of Cardiovascular Surgery Ziekenhuis Oost Limburg Genk Belgium

Department of Molecular Medicine and Surgery Department of Cardiac Surgery Karolinska Institutet Karolinska University Hospital Stockholm Sweden

Department of Surgery University of Oulu Oulu Finland

Department of Thoracic and Cardio Vascular Surgery University Hospital Jean Minjoz Besançon France

Division of Cardiac Surgery Ospedali Riuniti Trieste Italy

Division of Cardiothoracic and Vascular Surgery Pontchaillou University Hospital Rennes France

Division of Cardiothoracic and Vascular Surgery Robert Debré University Hospital Reims France

Hamburg University Heart Center Hamburg Germany

Heart Center Turku University Hospital and Department of Surgery University of Turku Turku Finland

Institute of Clinical and Experimental Medicine Prague Czech Republic

Prince Sultan Cardiac Center Al Hassa Saudi Arabia

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023056
003      
CZ-PrNML
005      
20201214125214.0
007      
ta
008      
201125s2020 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jtcvs.2019.06.039 $2 doi
035    __
$a (PubMed)31358340
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Biancari, Fausto $u Heart Center, Turku University Hospital and Department of Surgery, University of Turku, Turku, Finland; Department of Surgery, University of Oulu, Oulu, Finland. Electronic address: faustobiancari@yahoo.it.
245    10
$a Multicenter study on postcardiotomy venoarterial extracorporeal membrane oxygenation / $c F. Biancari, M. Dalén, A. Fiore, VG. Ruggieri, D. Saeed, K. Jónsson, G. Gatti, S. Zipfel, A. Perrotti, K. Bounader, A. Loforte, A. Lechiancole, M. Pol, C. Spadaccio, M. Pettinari, S. Ragnarsson, K. Alkhamees, G. Mariscalco, H. Welp, PC-ECMO Study Group,
520    9_
$a OBJECTIVES: The aim of this study was to identify the risk factors associated with early mortality after postcardiotomy venoarterial extracorporeal membrane oxygenation. METHODS: This is an analysis of the postcardiotomy extracorporeal membrane oxygenation registry, a retrospective multicenter cohort study including 781 patients aged more than 18 years who required venoarterial extracorporeal membrane oxygenation for cardiopulmonary failure after cardiac surgery from 2010 to 2018 at 19 cardiac surgery centers. RESULTS: After a mean venoarterial extracorporeal membrane oxygenation therapy of 6.9 ± 6.2 days, hospital and 1-year mortality were 64.4% and 67.2%, respectively. Hospital mortality after venoarterial extracorporeal membrane oxygenation therapy for more than 7 days was 60.5% (P = .105). Centers that had treated more than 50 patients with postcardiotomy venoarterial extracorporeal membrane oxygenation had a significantly lower hospital mortality than lower-volume centers (60.7% vs 70.7%, adjusted odds ratio, 0.58; 95% confidence interval, 0.41-0.82). The postcardiotomy extracorporeal membrane oxygenation score was derived by assigning a weighted integer to each independent pre-venoarterial extracorporeal membrane oxygenation predictors of hospital mortality as follows: female gender (1 point), advanced age (60-69 years, 2 points; ≥70 years, 4 points), prior cardiac surgery (1 point), arterial lactate 6.0 mmol/L or greater before venoarterial extracorporeal membrane oxygenation (2 points), aortic arch surgery (4 points), and preoperative stroke/unconsciousness (5 points). The hospital mortality rates according to the postcardiotomy extracorporeal membrane oxygenation score was 0 point, 45.6%; 1 point, 40.5%; 2 points, 51.1%; 3 points, 57.8%; 4 points, 70.7%; 5 points, 68.3%; 6 points, 77.5%; and 7 points or more, 89.7% (P < .0001). CONCLUSIONS: Age, female gender, prior cardiac surgery, preoperative acute neurologic events, aortic arch surgery, and increased arterial lactate were associated with increased risk of early mortality after postcardiotomy venoarterial extracorporeal membrane oxygenation. Center experience with postcardiotomy venoarterial extracorporeal membrane oxygenation may contribute to improved results.
650    _2
$a senioři $7 D000368
650    _2
$a kardiochirurgické výkony $x mortalita $7 D006348
650    _2
$a mimotělní membránová oxygenace $x mortalita $7 D015199
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hemodynamika $x fyziologie $7 D006439
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    _2
$a výsledek terapie $7 D016896
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Dalén, Magnus $u Department of Molecular Medicine and Surgery, Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
700    1_
$a Fiore, Antonio $u Department of Cardiothoracic Surgery, Henri Mondor University Hospital, AP-HP, Paris-Est University, Créteil, France.
700    1_
$a Ruggieri, Vito G $u Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France.
700    1_
$a Saeed, Diyar $u Cardiovascular Surgery, University Hospital of Duesseldorf, Dusseldorf, Germany.
700    1_
$a Jónsson, Kristján $u Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
700    1_
$a Gatti, Giuseppe $u Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy.
700    1_
$a Zipfel, Svante $u Hamburg University Heart Center, Hamburg, Germany.
700    1_
$a Perrotti, Andrea $u Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France.
700    1_
$a Bounader, Karl $u Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France.
700    1_
$a Loforte, Antonio $u Department of Cardiothoracic, Transplantation and Vascular Surgery, S. Orsola Hospital, University of Bologna, Bologna, Italy.
700    1_
$a Lechiancole, Andrea $u Cardiothoracic Department, University Hospital of Udine, Udine, Italy.
700    1_
$a Pol, Marek $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Spadaccio, Cristiano $u Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.
700    1_
$a Pettinari, Matteo $u Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium.
700    1_
$a Ragnarsson, Sigurdur $u Department of Cardiothoracic Surgery, University of Lund, Lund, Sweden.
700    1_
$a Alkhamees, Khalid $u Prince Sultan Cardiac Center, Al Hassa, Saudi Arabia.
700    1_
$a Mariscalco, Giovanni $u Department of Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester, Leicester, United Kingdom.
700    1_
$a Welp, Henryk $u Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany.
710    2_
$a PC-ECMO Study Group
773    0_
$w MED00003020 $t The Journal of thoracic and cardiovascular surgery $x 1097-685X $g Roč. 159, č. 5 (2020), s. 1844-1854.e6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31358340 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214125214 $b ABA008
999    __
$a ok $b bmc $g 1595375 $s 1113732
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 159 $c 5 $d 1844-1854.e6 $e 20190702 $i 1097-685X $m Journal of thoracic and cardiovascular surgery $n J Thorac Cardiovasc Surg $x MED00003020
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...